pembrolizumab in development Buyback: 6,000 Cr at 1,150/share signals management confidence in long-term value 19) Cipla US - Crossing $400 Mn Quarterly, Ventolin CGT Milestone FY26 US: ~$780 Mn | First AB-rated generic Ventolin with CGT approval Ciplas US business has been built methodically on respiratory leadership (inhaler franchise), and the generic Ventolin approval with Comparative Bioequivalence Study/CGT represents a significant competitive moat
The frequency of administration is crucial, as after seven or eight weeks, the dosage is typically reduced to a monthly schedule
Puede ser ms relevante en situaciones que alteran la homeostasis (p
Tumor associated macrophages: origin, recruitment, phenotypic diversity, and targeting
Most compounding pharmacies assign 28-90 day expiration dates, depending on their testing and stability data